Lantus solostar and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Lantus solostar (insulin glargine recombinant), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ventolin Hfa, and have Hyperglycemia.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Lantus solostar. It is created by eHealthMe based on reports of 41,389 people who have side effects when taking Lantus solostar from the FDA, and is updated regularly.

What is Lantus solostar?

Lantus solostar has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 41,639 Lantus solostar users. Check the latest studies of Lantus solostar.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 922 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

41,389 people reported to have side effects when taking Lantus solostar.
Among them, 17 people (0.04%) have Urination - excessive volume.

Could Lantus solostar cause Urination - excessive volume?

Among these 17 people:

How long have people been on Lantus solostar when they have Urination - excessive volume? *

What is the gender of people who have Urination - excessive volume when taking Lantus solostar? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Urination - excessive volume when taking Lantus solostar? *

What are other drugs people take besides Lantus solostar? *

What are other side effects people have besides Urination - excessive volume? *

Blood Glucose Increased: 9 people, 52.94%
Dizziness: 6 people, 35.29%
Fatigue (feeling of tiredness): 6 people, 35.29%
Weakness: 4 people, 23.53%
Hyperglycemia (high blood sugar): 4 people, 23.53%
Headache (pain in head): 4 people, 23.53%
Thirst - Excessive: 4 people, 23.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 17.65%
Weight Decreased: 3 people, 17.65%
Pain In Extremity: 3 people, 17.65%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
Hyperglycemia (high blood sugar): 2 people, 11.76%
Urination - Painful: 1 person, 5.88%
Small Intestinal Bacterial Overgrowth: 1 person, 5.88%
Sleep Disorder: 1 person, 5.88%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
Hiv Infection: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Heart Disease: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus solostar and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lantus solostar:

Lantus solostar (41,639 reports)

Browse all side effects of Lantus solostar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (922 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant (the active ingredients of Lantus solostar) and Lantus solostar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.